Merxin designs and supplies inhaler devices: capsule dry powder inhaler (MRX003), soft mist inhaler (MRX004), and a dual cavity multidose dry powder inhaler (MRX006). Merxin is active in the fields of pharmaceuticals and inhaled cannabinoid therapies.
We are inhaler experts. We create, develop and supply device platforms for evaluation through to commercial supply. Our customers take our devices and combine them with their drug formulation to make final dosage forms that are supplied to users and patients.
Our devices are available for commercial launch, clinical trials and in vitro testing. Contact us on info@merxin.com.